News

Track Our News on

2023-08-10

MindRank Secures Funding from the Dynamic Resilience Program for its Pan-European Collaborative Project

2023-07-29

ICML 2023 | Rethinking Explaining Graph Neural Networks via Non-parametric Subgraph Matching

2023-07-18

MindRank Secures Over $20 Million in A+ Round Financing, Propelling Innovative Drug Pipeline and AI Platform Commercialization

2023-06-12

MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China

2023-04-05

Commun. Chem. (Nature) | Pharmacophoric-Constrained Heterogeneous Graph Transformer Model for Molecular Property Prediction

2023-01-17

MindRank Made the List of 2022 China's Top 10 Most Potential ScienceAI Startups by Synced

2023-01-12

MindRank was Nominated for the 2022 Venture50 List by Zero2IPO Group and Pedaily

2022-12-23

MindRank Announces U.S. FDA Clearance of IND Application for MDR-001, a Novel GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes and Obesity

2022-12-19

MindRank was Nominated "the TOP100 Most Innovative Medical Technology Products (Solutions) 2022" by VBDATA

2022-12-16

MindRank Features in the 2022 Galen Growth | Global HealthTech Insights HealthTech 250 List

2022-12-06

MindRank is Awarded the 4th China Health Innovation Platform Award

2022-11-25

MindRank’s Co-Authorship Paper Won the 2021 Chinese Scientists with Cell Press Best Paper Award

3 / 5